Editing GSK plc (section)

===SB Pharmco Puerto Rico===
In 2010, the US Department of Justice announced that GSK would pay a US$150{{nbsp}}million criminal fine and forfeiture, and a civil settlement of US$600{{nbsp}}million under the False Claims Act. The fines stemmed from production of improperly made and adulterated drugs from 2001 to 2005, at GSK's subsidiary, SB Pharmco Puerto Rico Inc., in Cidra, Puerto Rico, which at the time produced US$5.5&nbsp;billion of products each year. The drugs involved were [[Kytril]], an antiemetic; [[Bactroban]], used to treat skin infections; Paxil, the anti-depressant; and [[Avandamet]], a diabetes drug.<ref>{{Cite web |date=26 October 2010 |title=Office of Public Affairs {{!}} GlaxoSmithKline to Plead Guilty & Pay $750 Million to Resolve Criminal and Civil Liability Regarding Manufacturing Deficiencies at Puerto Rico Plant {{!}} United States Department of Justice |url=https://www.justice.gov/opa/pr/glaxosmithkline-plead-guilty-pay-750-million-resolve-criminal-and-civil-liability-regarding |url-status=live |archive-url=https://web.archive.org/web/20141019113737/https://www.justice.gov/opa/pr/glaxosmithkline-plead-guilty-pay-750-million-resolve-criminal-and-civil-liability-regarding |archive-date=19 October 2014 |access-date=11 September 2023 |website=www.justice.gov |language=en}}</ref> GSK closed the factory in 2009.<ref name="NYTPuerto">{{cite news |last1=Harris |first1=Gardiner |last2=Wilson |first2=Duff |date=26 October 2010 |title=Glaxo to Pay $750 Million for Sale of Bad Products |work=[[The New York Times]] |url=https://www.nytimes.com/2010/10/27/business/27drug.html |url-status=live |archive-url=https://web.archive.org/web/20230405082107/https://www.nytimes.com/2010/10/27/business/27drug.html |archive-date=5 April 2023}}</ref>

The case began in 2002, when GSK sent experts to fix problems cited by the FDA. The lead inspector recommended recalls of defective products, but they were not authorised; she was fired in 2003, and filed a whistleblower lawsuit. In 2005, federal marshals seized US$2{{nbsp}}billion worth of products, the largest such seizure in history. In the 2010 settlement SB Pharmco pleaded guilty to criminal charges, and agreed to pay US$150&nbsp;million in a criminal fine and forfeiture, at that time the largest such payment ever by a manufacturer of adulterated drugs, and US$600&nbsp;million in civil penalties to settle the civil lawsuit.<ref name=NYTPuerto/>